Invention Grant
- Patent Title: Gender-specific markers for diagnosing prognosis and determining treatment strategy for renal cancer patients
-
Application No.: US15779108Application Date: 2017-09-27
-
Publication No.: US11243206B2Publication Date: 2022-02-08
- Inventor: Yeong Jin Choi
- Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- Applicant Address: KR Seoul
- Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- Current Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: Vorys. Sater, Seymour and Pease LLP
- Agent Mih Suhn Koh
- Priority: KR10-2016-0124785 20160928,KR10-2017-0123572 20170925
- International Application: PCT/KR2017/010741 WO 20170927
- International Announcement: WO2018/062862 WO 20180405
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574 ; C12Q1/6886
Abstract:
The present invention relates to markers for diagnosing the difference in effects of renal cancer treatment or the prognosis of renal cancer patients, according to the gender of renal cancer patients. The survival rate and recurrence rate of renal cancer of a particular gender respectively relate to the mutation of genes, of the present invention, in renal cancer patients, and thus the mutated genes of the present invention can be used as markers in predicting, on the basis of gender, the difference in effects of renal cancer treatment or the prognosis of renal cancer patients.
Public/Granted literature
Information query
